Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2
NCT ID: NCT05837819
Last Updated: 2025-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
135 participants
INTERVENTIONAL
2023-02-14
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer's
NCT02502045
Lighting for Older Adults With Dementia
NCT05697757
Effects of Light-therapy in Alzheimer's Disease
NCT02686190
Determining How Indoor Lighting Affects the Brain Health of Older Adults
NCT05978934
Using Environmental Light Therapy to Improve Sleep and Neuropsychiatric Symptoms in Dementia
NCT02829892
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Lighting Intervention
Lighting intervention designed to effect the circadian system then will receive the control lighting intervention.
Active Lighting Intervention
Lighting intervention using high light levels designed to effect the circadian system
Control Lighting Intervention
Lighting intervention using low light levels designed to not effect the circadian system
Control Lighting Intervention
Lighting intervention using low light levels designed to not effect the circadian system
Control Lighting Intervention
Lighting intervention using low light levels designed to not effect the circadian system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active Lighting Intervention
Lighting intervention using high light levels designed to effect the circadian system
Control Lighting Intervention
Lighting intervention using low light levels designed to not effect the circadian system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sleep disturbance with a Pittsburgh Sleep Quality Index score ≥5
Exclusion Criteria
* Obstructing cataracts
* Severe macular degeneration
* Use of sleep medication
* Use of oral melatonin
* untreated moderate to severe sleep apnea
* Severe restless leg syndrome
* Blindness
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Icahn School of Medicine at Mount Sinai
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mariana Figueiro
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mariana Figueiro, PhD
Role: PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Icahn School of Medicine at Mount Sinai
Albany, New York, United States
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY-20-01736 Aim 2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.